Xagenic, a Toronto, Canada-based molecular diagnostics company developing the lab-free Xagenic X1™ platform for use at the point of care, raised CAD$15M in funding.
The company intends to use the funds to accelerate its development efforts.
Led by Timothy I. Still, Chief Executive Officer, Xagenic provides the Xagenic X1™ platform, which will allow users to perform lab-quality molecular diagnostic tests in the physician office with a time-to-result of 20 minutes.
The company also has a San Francisco office.